Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands

Short peptides derived from intracellular proteins and presented on MHC class I molecules on the cell surface serve as a showcase for the immune system to detect pathogenic or malignant alterations inside the cell, and the sequencing and analysis of the presented peptide pool has received considerable attention over the last two decades. In this review, we give a comprehensive presentation of the methods employed for the large-scale qualitative and quantitative analysis of the MHC class I ligandome. Furthermore, we focus on insights gained into the underlying processing pathway, especially involving the roles of the proteasome, the TAP complex, and the peptide specificities and motifs of MHC molecules. The identification of post-translational modifications in MHC ligands and their implications for processing are also considered. Finally, we review the correlations of the ligandome to the proteome and the transcriptome.

[1]  J. Yewdell,et al.  Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? , 1996, Journal of immunology.

[2]  J. Vázquez,et al.  A post‐translational modification of nuclear proteins, NG,NG‐dimethyl‐Arg, found in a natural HLA class I peptide ligand , 2000, Protein science : a publication of the Protein Society.

[3]  T. Elliott,et al.  Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL. , 1999, Journal of immunology.

[4]  Daniel C Liebler,et al.  Quantitative analysis of modified proteins by LC-MS/MS of peptides labeled with phenyl isocyanate. , 2003, Journal of proteome research.

[5]  Mark D'Ascenzo,et al.  8‐Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease , 2007, Proteomics.

[6]  D M Desiderio,et al.  Preparation of stable isotope-incorporated peptide internal standards for field desorption mass spectrometry quantification of peptides in biologic tissue. , 1983, Biomedical mass spectrometry.

[7]  J. Martinko,et al.  Binding of peptides lacking consensus anchor residue alters H-2Ld serologic recognition. , 1993, Journal of immunology.

[8]  O. Jensen,et al.  Assessment of lectin and HILIC based enrichment protocols for characterization of serum glycoproteins by mass spectrometry. , 2008, Journal of proteomics.

[9]  Hans-Georg Rammensee,et al.  Integrated functional genomics approach for the design of patient-individual antitumor vaccines. , 2002, Cancer research.

[10]  J. Sidney,et al.  Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus. , 2010, Human immunology.

[11]  A. Nouri,et al.  Comparative Study between Direct Mild Acid Extraction and Immunobead Purification Technique for Isolation of HLA Class I-Associated Peptides , 2002, Urologia Internationalis.

[12]  J. Trowsdale,et al.  Dynamics of proteasome distribution in living cells , 1997, The EMBO journal.

[13]  J. Neefjes,et al.  Peptide size selection by the major histocompatibility complex-encoded peptide transporter , 1994, The Journal of experimental medicine.

[14]  B. J. Van den Eynde,et al.  Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. , 2001, Current opinion in immunology.

[15]  M. Feltkamp,et al.  Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. , 1995, Journal of immunology.

[16]  Nina Hillen,et al.  Features of TAP‐independent MHC class I ligands revealed by quantitative mass spectrometry , 2008, European journal of immunology.

[17]  K. Parker,et al.  HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. , 1993, Journal of immunology.

[18]  H. Rammensee,et al.  HLA-A2 subtypes are functionally distinct in peptide binding and presentation , 1995, The Journal of experimental medicine.

[19]  A Sette,et al.  The peptide-binding motif for the human transporter associated with antigen processing , 1995, The Journal of experimental medicine.

[20]  M. Oldstone,et al.  Genetically Encoded and Post-translationally Modified Forms of a Major Histocompatibility Complex Class I-restricted Antigen Bearing a Glycosylation Motif Are Independently Processed and Co-presented to Cytotoxic T Lymphocytes* , 1999, The Journal of Biological Chemistry.

[21]  V Brusic,et al.  Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. , 1998, Journal of immunology.

[22]  Hans-Georg Rammensee,et al.  Two new proteases in the MHC class I processing pathway , 2000, Nature Immunology.

[23]  Lawrence Steinman,et al.  T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis , 1986, Nature.

[24]  A. Verkman,et al.  Evidence for phosphorylation of serine 753 in CFTR using a novel metal‐ion affinity resin and matrix‐assisted laser desorption mass spectrometry , 1997, Protein science : a publication of the Protein Society.

[25]  V. Engelhard,et al.  Post-translational modifications of naturally processed MHC-binding epitopes. , 2006, Current opinion in immunology.

[26]  Jacques Neefjes,et al.  A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. , 2004, Immunity.

[27]  R. Henderson,et al.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.

[28]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[29]  R. Aebersold,et al.  Mass spectrometry in proteomics. , 2001, Chemical reviews.

[30]  Jonathan W. Yewdell,et al.  Immune recognition of a human renal cancer antigen through post-translational protein splicing , 2004, Nature.

[31]  Hans-Georg Rammensee,et al.  MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.

[32]  Hans-Georg Rammensee,et al.  Distorted Relation between mRNA Copy Number and Corresponding Major Histocompatibility Complex Ligand Density on the Cell Surface*S , 2007, Molecular & Cellular Proteomics.

[33]  R. Henderson,et al.  HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. , 1992, Science.

[34]  Forest M. White,et al.  Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in Vivo , 2000, The Journal of experimental medicine.

[35]  J. Sidney,et al.  Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.

[36]  O. Johnell,et al.  The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans , 2005, European journal of immunology.

[37]  Hans-Georg Rammensee,et al.  MHC Ligands and Peptide Motifs , 1998, Molecular Biology Intelligence Unit.

[38]  P. Edman,et al.  A method for the determination of amino acid sequence in peptides. , 1949, Archives of biochemistry.

[39]  P. Cresswell,et al.  Disulfide bond isomerization and the assembly of MHC class I-peptide complexes. , 2002, Immunity.

[40]  H. Rammensee,et al.  Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling , 2004, Nature Biotechnology.

[41]  Mark Lindsey,et al.  Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501 , 1997, Immunogenetics.

[42]  P. Cresswell,et al.  Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer , 2007, Nature Immunology.

[43]  E. Caron,et al.  The MHC class I peptide repertoire is molded by the transcriptome , 2008, The Journal of experimental medicine.

[44]  S. Stevanović,et al.  Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules. , 1999, Seminars in immunology.

[45]  B. J. Van den Eynde,et al.  Splicing of Distant Peptide Fragments Occurs in the Proteasome by Transpeptidation and Produces the Spliced Antigenic Peptide Derived from Fibroblast Growth Factor-5 , 2010, The Journal of Immunology.

[46]  A. Goldberg,et al.  Interferon-γ Can Stimulate Post-proteasomal Trimming of the N Terminus of an Antigenic Peptide by Inducing Leucine Aminopeptidase* , 1998, The Journal of Biological Chemistry.

[47]  A. Purcell,et al.  The use of post-source decay in matrix-assisted laser desorption/ionisation mass spectrometry to delineate T cell determinants. , 2001, Journal of immunological methods.

[48]  D. Finley,et al.  Recognition and processing of ubiquitin-protein conjugates by the proteasome. , 2009, Annual review of biochemistry.

[49]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[50]  P. Cresswell,et al.  Tapasin and ERp57 form a stable disulfide‐linked dimer within the MHC class I peptide‐loading complex , 2005, The EMBO journal.

[51]  S. Gendler,et al.  Designer Glycopeptides for Cytotoxic T Cell–based Elimination of Carcinomas , 2004, The Journal of experimental medicine.

[52]  L. Gardner,et al.  Human Leukocyte Antigen Class I Supertypes and HIV-1 Control in African Americans , 2009, Journal of Virology.

[53]  Ilan Beer,et al.  The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells* , 2006, Molecular & Cellular Proteomics.

[54]  J. Neefjes,et al.  Translocation of long peptides by transporters associated with antigen processing (TAP) , 1996, European journal of immunology.

[55]  J. Coligan,et al.  Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype. , 1985, Journal of immunology.

[56]  F. Ginhoux,et al.  Quantifying Recruitment of Cytosolic Peptides for HLA Class I Presentation: Impact of TAP Transport1 , 2003, The Journal of Immunology.

[57]  D. Wiley,et al.  Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.

[58]  S. Gygi,et al.  Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Shabanowitz,et al.  Processing of a Class I-Restricted Epitope from Tyrosinase Requires Peptide N-Glycanase and the Cooperative Action of Endoplasmic Reticulum Aminopeptidase 1 and Cytosolic Proteases1 , 2006, The Journal of Immunology.

[60]  A Sette,et al.  Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.

[61]  Jeffrey K. Mito,et al.  An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order , 2006, Science.

[62]  Cécile Gouttefangeas,et al.  Identification of tumor‐associated MHC class I ligands by a novel T cell‐independent approach , 2000, European journal of immunology.

[63]  S. Nathenson,et al.  Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule , 1990, Nature.

[64]  T. Elliott,et al.  Presentation of Cytosolic Glycosylated Peptides by Human Class I Major Histocompatibility Complex Molecules in Vivo , 1999, The Journal of experimental medicine.

[65]  Nina Hillen,et al.  Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA‐B44 supertype , 2008, European journal of immunology.

[66]  A. Agulnik,et al.  The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. , 1997, Immunity.

[67]  A. Schmidt,et al.  A novel strategy for quantitative proteomics using isotope‐coded protein labels , 2005, Proteomics.

[68]  M. Münchbach,et al.  Quantitation and facilitated de novo sequencing of proteins by isotopic N-terminal labeling of peptides with a fragmentation-directing moiety. , 2000, Analytical chemistry.

[69]  M. Lotze,et al.  Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[70]  Anne M Evans,et al.  Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy , 2006, Proceedings of the National Academy of Sciences.

[71]  Martin Gilar,et al.  Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins. , 2003, Analytical chemistry.

[72]  K. Tanaka,et al.  Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. , 1994, Journal of biochemistry.

[73]  H. Rammensee,et al.  Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands. , 2009, Journal of proteome research.

[74]  H. Rammensee,et al.  Discrete Cleavage Motifs of Constitutive and Immunoproteasomes Revealed by Quantitative Analysis of Cleavage Products , 2001, The Journal of experimental medicine.

[75]  W Keilholz,et al.  Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Maria L. Wei,et al.  HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides , 1992, Nature.

[77]  V. Engelhard,et al.  Tyrosinase degradation via two pathways during reverse translocation to the cytosol. , 2001, Biochemical and biophysical research communications.

[78]  D. Kwiatkowski,et al.  HLA class I typing by PCR: HLA-B27 and an African B27 subtype , 1991, The Lancet.

[79]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[80]  A. Goldberg,et al.  The Sizes of Peptides Generated from Protein by Mammalian 26 and 20 S Proteasomes , 1999, The Journal of Biological Chemistry.

[81]  J. Bluestone,et al.  Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition , 1992, The Journal of experimental medicine.

[82]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[83]  J. Shabanowitz,et al.  An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins , 1996, The Journal of experimental medicine.

[84]  H. Rammensee,et al.  SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.

[85]  Akira Hattori,et al.  An IFN-γ–induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I–presented peptides , 2002, Nature Immunology.

[86]  Andrew Emili,et al.  De novo peptide sequencing and quantitative profiling of complex protein mixtures using mass-coded abundance tagging , 2002, Nature Biotechnology.

[87]  A. S. Juncker,et al.  Systematic Characterisation of Cellular Localisation and Expression Profiles of Proteins Containing MHC Ligands , 2009, PloS one.

[88]  D. Heckerman,et al.  Adaptive Interactions between HLA and HIV-1: Highly Divergent Selection Imposed by HLA Class I Molecules with Common Supertype Motifs , 2010, The Journal of Immunology.

[89]  R. Vierkant,et al.  HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine. , 2009, Vaccine.

[90]  J. Shabanowitz,et al.  Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for presentation of transformed self , 2008, Nature Immunology.

[91]  B. Gückel,et al.  A MAGE-A1 HLA-A A*0201 epitope identified by mass spectrometry. , 2001, Cancer research.

[92]  S. Gygi,et al.  Quantitative analysis of complex protein mixtures using isotope-coded affinity tags , 1999, Nature Biotechnology.

[93]  Bjoern Peters,et al.  HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.

[94]  H. Rammensee,et al.  Peptides naturally presented by MHC class I molecules. , 1993, Annual review of immunology.

[95]  T. Boon,et al.  An Antigenic Peptide Produced by Peptide Splicing in the Proteasome , 2004, Science.

[96]  Muthuraman Sathiamurthy,et al.  Toward a Definition of Self: Proteomic Evaluation of the Class I Peptide Repertoire1 , 2004, The Journal of Immunology.

[97]  M. Groettrup,et al.  Proteasomes in immune cells: more than peptide producers? , 2010, Nature Reviews Immunology.

[98]  N. Shastri,et al.  The final touches make perfect the peptide-MHC class I repertoire. , 2007, Immunity.

[99]  M. Bruening,et al.  Techniques for phosphopeptide enrichment prior to analysis by mass spectrometry. , 2009, Mass spectrometry reviews (Print).

[100]  J. Yewdell,et al.  The DRiP hypothesis decennial: support, controversy, refinement and extension. , 2006, Trends in immunology.